Research and HIPAA: Why Is It Still a Problem - CI0423
-
Martha Arvin , VP, Chief Compliance Officer, Erlanger Health System.
Joseph Dickinson, Member, Nexsen Pruet, PLLC.
2023-04-26
-
Uses and disclosures of PHI for research remains a problem for covered entities and researchers
-
Why the improper use and disclosure of PHI for research is a risk for patients/subjects
-
Confusion over the role of the IRB, requirements of the Common Rule and the HIPAA regulations
THIS DOCUMENT IS ONLY AVAILABLE TO MEMBERS OR ATTENDEES. PLEASE LOG IN OR PURCHASE ACCESS.
THIS RECORDING IS ONLY AVAILABLE TO ATTENDEES AND PURCHASERS. PLEASE LOG IN OR PURCHASE ACCESS.